Cardiovascular efficacy and safety of bococizumab in high-risk patients

P. M. Ridker, J. Revkin, P. Amarenco, R. Brunell, M. Curto, F. Civeira, M. Flather, R. J. Glynn, J. Gregoire, J. W. Jukema, Y. Karpov, J. J.P. Kastelein, W. Koenig, A. Lorenzatti, P. Manga, U. Masiukiewicz, M. Miller, A. Mosterd, J. Murin, J. C. NicolauS. Nissen, P. Ponikowski, R. D. Santos, P. F. Schwartz, H. Soran, H. White, R. S. Wright, M. Vrablik, C. Yunis, C. L. Shear, J. C. Tardif, SPIRE Cardiovascular Outcome Investigators, S. N. Stranks, P. E. Aylward

    Research output: Contribution to journalArticlepeer-review

    380 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Cardiovascular efficacy and safety of bococizumab in high-risk patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences